NIH Roadmap Nanomedicine Development Centers Informational Meeting in Bethesda, MD on January 27, 2006

Notice Number: NOT-RM-06-010

Key Dates
Release Date: January 13, 2006

Issued by
National Institutes of Health (NIH), (http://www.nih.gov)

The purpose of this notice is to inform potential applicants for an NIH Nanomedicine Development Center (NDC) that an informational meeting will be held to describe the NIH Roadmap Nanomedicine Initiative. It is anticipated that an NIH Roadmap Request for Applications (RFA-RM-06-007) for NDC awards will be published in the NIH guide prior to the meeting.

The meeting will be broadcast live on the internet at http://videocast.nih.gov/default.asp . Questions before or during the meeting broadcast may be submitted to by email to Nanomed@nih.gov. Include “Nanomed Info” in the subject line.

The NIH Roadmap Nanomedicine Initiative has established a collaborative network of Nanomedicine Development Centers (NDC). After a two-year planning process, four NDCs were awarded for five years beginning in 2005 (see http://nihroadmap.nih.gov/nanomedicine/fundedresearch.asp). This year, additional centers will be awarded to complete the network of NDCs. The RFA will be an open competition, and all qualified applicants who are interested in assembling and leading a multidisciplinary team are invited to attend this meeting and apply for an NDC award.

Nanomedicine is an emerging field that is expected to reap tremendous benefits for human health. Each of these multidisciplinary centers will consist of outstanding investigators from a variety of disciplines including biologists, engineers, mathematicians, physical scientists and clinicians who will develop innovative studies to measure the physical properties of molecules and supramolecular complexes within living cells. The information obtained will be used to understand the design principles of molecular assemblies and complexes which operate at the nanoscale in cells. The long-term goal of the NIH Nanomedicine initiative is to engineer new complexes or nanoscale molecular components that will lead to highly specific treatments to cure disease and/or repair damaged tissue to improve human health.

Details of the NIH Nanomedicine program, the RFA, review of the applications, and the award management will be discussed at the meeting.

Inquiries

Specific programmatic inquiries concerning the Nanomedicine Roadmap Initiative should be directed to:

Richard S. Fisher, Ph.D.
Nanomedicine Project Team Leader
National Eye Institute
5635 Fishers Lane, Suite 1300
Bethesda , MD 20892-9300 ( Rockville , MD 20852 for overnight delivery services)
Telephone: (301) 451-2020


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.